Do analysts recommend ARQ or BLGO?

ARQ currently has a consensus target price of $5.00, indicating a potential upside of 160.42%. Given ARQ's stronger consensus rating and higher probable upside, equities analysts clearly believe ARQ is more favorable than BioLargo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ARQ 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, ARQ or BLGO?

BioLargo has lower revenue, but higher earnings than ARQ. BioLargo is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ARQ $120.34M 0.70 -$52.61M -$1.26 N/A BioLargo $12.23M 2.31 -$3.50M -$0.05 N/A

Is ARQ or BLGO more profitable?

BioLargo has a net margin of -11.45% compared to ARQ's net margin of -42.33%. ARQ's return on equity of -2.54% beat BioLargo's return on equity. Company Net Margins Return on Equity Return on Assets ARQ -42.33% -2.54% -1.88% BioLargo -11.45% -39.90% -22.06%

Do analysts recommend NTIC or BLGO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Northern Technologies International 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate BLGO or FSI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Flexible Solutions International 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00

Do analysts rate BLGO or AVD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

BioLargo (BLGO) Competitors

$0.08 -0.01 (-5.56%)

As of 03:49 PM Eastern

Compare

BLGO vs. ARQ, NTIC, FSI, AVD, and BIOX

Should you buy BioLargo stock or one of its competitors? BioLargo's main competitors and comparable companies include ARQ (ARQ), Northern Technologies International (NTIC), Flexible Solutions International (FSI), American Vanguard (AVD), and Bioceres Crop Solutions (BIOX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does BioLargo compare to ARQ?

ARQ (NASDAQ:ARQ) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

In the previous week, ARQ had 3 more articles in the media than BioLargo. MarketBeat recorded 3 mentions for ARQ and 0 mentions for BioLargo. ARQ's average media sentiment score of 0.60 beat BioLargo's score of 0.00 indicating that ARQ is being referred to more favorably in the media.

Company	Overall Sentiment
ARQ	Positive
BioLargo	Neutral

BioLargo has lower revenue, but higher earnings than ARQ. BioLargo is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ARQ	$120.34M	0.70	-$52.61M	-$1.26	N/A
BioLargo	$12.23M	2.31	-$3.50M	-$0.05	N/A

ARQ has a beta of 2.05, suggesting that its share price is 105% more volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market.

18.5% of ARQ shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 20.1% of ARQ shares are owned by insiders. Comparatively, 19.3% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

ARQ currently has a consensus target price of $5.00, indicating a potential upside of 160.42%. Given ARQ's stronger consensus rating and higher probable upside, equities analysts clearly believe ARQ is more favorable than BioLargo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ARQ	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

BioLargo has a net margin of -11.45% compared to ARQ's net margin of -42.33%. ARQ's return on equity of -2.54% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ARQ	-42.33%	-2.54%	-1.88%
BioLargo	-11.45%	-39.90%	-22.06%

Summary

ARQ beats BioLargo on 11 of the 15 factors compared between the two stocks.

How does BioLargo compare to Northern Technologies International?

Northern Technologies International (NASDAQ:NTIC) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Northern Technologies International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

32.9% of Northern Technologies International shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 24.9% of Northern Technologies International shares are held by company insiders. Comparatively, 19.3% of BioLargo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Northern Technologies International has a beta of 0.18, suggesting that its share price is 82% less volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market.

In the previous week, Northern Technologies International had 2 more articles in the media than BioLargo. MarketBeat recorded 2 mentions for Northern Technologies International and 0 mentions for BioLargo. Northern Technologies International's average media sentiment score of 0.46 beat BioLargo's score of 0.00 indicating that Northern Technologies International is being referred to more favorably in the media.

Company	Overall Sentiment
Northern Technologies International	Neutral
BioLargo	Neutral

Northern Technologies International has higher revenue and earnings than BioLargo. Northern Technologies International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Northern Technologies International	$84.24M	0.88	$20K	-$0.12	N/A
BioLargo	$12.23M	2.31	-$3.50M	-$0.05	N/A

Northern Technologies International has a net margin of -1.26% compared to BioLargo's net margin of -11.45%. Northern Technologies International's return on equity of -0.45% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Northern Technologies International	-1.26%	-0.45%	-0.33%
BioLargo	-11.45%	-39.90%	-22.06%

Summary

Northern Technologies International beats BioLargo on 11 of the 13 factors compared between the two stocks.

How does BioLargo compare to Flexible Solutions International?

BioLargo (NASDAQ:BLGO) and Flexible Solutions International (NYSE:FSI) are both small-cap materials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Flexible Solutions International has higher revenue and earnings than BioLargo. Flexible Solutions International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.31	-$3.50M	-$0.05	N/A
Flexible Solutions International	$35.58M	2.08	$2.78M	-$0.24	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Flexible Solutions International	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, BioLargo's average media sentiment score of 0.00 equaled Flexible Solutions International'saverage media sentiment score.

Company	Overall Sentiment
BioLargo	Neutral
Flexible Solutions International	Neutral

BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, Flexible Solutions International has a beta of 1.7, suggesting that its share price is 70% more volatile than the broader market.

0.0% of BioLargo shares are held by institutional investors. Comparatively, 54.3% of Flexible Solutions International shares are held by institutional investors. 19.3% of BioLargo shares are held by insiders. Comparatively, 35.8% of Flexible Solutions International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Flexible Solutions International has a net margin of 10.80% compared to BioLargo's net margin of -11.45%. Flexible Solutions International's return on equity of 10.61% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
Flexible Solutions International	10.80%	10.61%	7.32%

Summary

Flexible Solutions International beats BioLargo on 11 of the 13 factors compared between the two stocks.

How does BioLargo compare to American Vanguard?

BioLargo (NASDAQ:BLGO) and American Vanguard (NYSE:AVD) are both small-cap materials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

0.0% of BioLargo shares are held by institutional investors. Comparatively, 79.0% of American Vanguard shares are held by institutional investors. 19.3% of BioLargo shares are held by insiders. Comparatively, 5.6% of American Vanguard shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, BioLargo's average media sentiment score of 0.00 equaled American Vanguard'saverage media sentiment score.

Company	Overall Sentiment
BioLargo	Neutral
American Vanguard	Neutral

BioLargo has higher earnings, but lower revenue than American Vanguard. BioLargo is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.31	-$3.50M	-$0.05	N/A
American Vanguard	$515.11M	0.10	-$49.88M	-$1.90	N/A

American Vanguard has a net margin of -10.70% compared to BioLargo's net margin of -11.45%. American Vanguard's return on equity of -9.05% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
American Vanguard	-10.70%	-9.05%	-2.78%

Summary

American Vanguard beats BioLargo on 7 of the 11 factors compared between the two stocks.

How does BioLargo compare to Bioceres Crop Solutions?

Bioceres Crop Solutions (NASDAQ:BIOX) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

Bioceres Crop Solutions currently has a consensus target price of $2.00, suggesting a potential upside of 458.66%. Given Bioceres Crop Solutions' stronger consensus rating and higher probable upside, equities research analysts clearly believe Bioceres Crop Solutions is more favorable than BioLargo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioceres Crop Solutions	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Bioceres Crop Solutions has a beta of 0.44, suggesting that its stock price is 56% less volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

In the previous week, Bioceres Crop Solutions had 1 more articles in the media than BioLargo. MarketBeat recorded 1 mentions for Bioceres Crop Solutions and 0 mentions for BioLargo. Bioceres Crop Solutions' average media sentiment score of 1.84 beat BioLargo's score of 0.00 indicating that Bioceres Crop Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Bioceres Crop Solutions	Very Positive
BioLargo	Neutral

17.7% of Bioceres Crop Solutions shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 19.3% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

BioLargo has a net margin of -11.45% compared to Bioceres Crop Solutions' net margin of -94.76%. Bioceres Crop Solutions' return on equity of -39.11% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioceres Crop Solutions	-94.76%	-39.11%	-9.45%
BioLargo	-11.45%	-39.90%	-22.06%

BioLargo has lower revenue, but higher earnings than Bioceres Crop Solutions. BioLargo is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioceres Crop Solutions	$238.30M	0.10	-$54.40M	-$3.66	N/A
BioLargo	$12.23M	2.31	-$3.50M	-$0.05	N/A

Summary

Bioceres Crop Solutions beats BioLargo on 9 of the 14 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BLGO vs. The Competition

Export

Metric	BioLargo	Chemicals Industry	Materials Sector	NASDAQ Exchange
Market Cap	$28.20M	$11.17B	$4.75B	$13.03B
Dividend Yield	N/A	2.92%	4.73%	14.03%
P/E Ratio	-8.50	38.00	25.48	25.61
Price / Sales	2.31	48.54	16,510.75	108.08
Price / Cash	N/A	14.92	24.50	35.00
Price / Book	8.50	3.19	10.06	6.44
Net Income	-$3.50M	$222.40M	$157.81M	$360.47M
7 Day Performance	N/A	-1.51%	-1.70%	-1.03%
1 Month Performance	N/A	-3.93%	-3.97%	-3.70%
1 Year Performance	N/A	16.75%	22.13%	3.62%

BioLargo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BLGO BioLargo	N/A	$0.09 -5.6%	N/A	-49.8%	$28.20M	$12.23M	N/A	30
ARQ ARQ	3.6394 of 5 stars	$2.01 -1.5%	$5.00 +148.8%	-71.8%	$87.77M	$123.44M	N/A	202
NTIC Northern Technologies International	2.4561 of 5 stars	$7.85 -0.1%	N/A	+0.0%	$74.54M	$91.84M	N/A	94	News Coverage
FSI Flexible Solutions International	1.781 of 5 stars	$5.80 -0.3%	N/A	-39.0%	$74.08M	$35.58M	17.58	78
AVD American Vanguard	0.9727 of 5 stars	$1.92 -5.5%	N/A	-67.8%	$56.61M	$510.32M	N/A	739	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BLGO) was last updated on 9/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioLargo (BLGO) Competitors

BLGO vs. ARQ, NTIC, FSI, AVD, and BIOX

How does BioLargo compare to ARQ?

Summary

How does BioLargo compare to Northern Technologies International?

Summary

How does BioLargo compare to Flexible Solutions International?

Summary

How does BioLargo compare to American Vanguard?

Summary

How does BioLargo compare to Bioceres Crop Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLGO vs. The Competition

BioLargo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioLargo (BLGO) Competitors

BLGO vs. ARQ, NTIC, FSI, AVD, and BIOX

How does BioLargo compare to ARQ?

Does the media refer more to ARQ or BLGO?

Which has stronger earnings & valuation, ARQ or BLGO?

Which has more volatility and risk, ARQ or BLGO?

Do insiders and institutionals believe in ARQ or BLGO?

Do analysts recommend ARQ or BLGO?

Is ARQ or BLGO more profitable?

Summary

How does BioLargo compare to Northern Technologies International?

Do analysts recommend NTIC or BLGO?

Do insiders & institutionals hold more shares of NTIC or BLGO?

Which has more risk & volatility, NTIC or BLGO?

Does the media prefer NTIC or BLGO?

Which has stronger earnings and valuation, NTIC or BLGO?

Is NTIC or BLGO more profitable?

Summary

How does BioLargo compare to Flexible Solutions International?

Which has stronger earnings and valuation, BLGO or FSI?

Do analysts rate BLGO or FSI?

Does the media favor BLGO or FSI?

Which has more volatility & risk, BLGO or FSI?

Do institutionals & insiders have more ownership in BLGO or FSI?

Is BLGO or FSI more profitable?

Summary

How does BioLargo compare to American Vanguard?

Do institutionals & insiders hold more shares of BLGO or AVD?

Which has more volatility & risk, BLGO or AVD?

Do analysts rate BLGO or AVD?

Does the media prefer BLGO or AVD?

Which has stronger valuation & earnings, BLGO or AVD?

Is BLGO or AVD more profitable?

Summary

How does BioLargo compare to Bioceres Crop Solutions?

Do analysts prefer BIOX or BLGO?

Which has more volatility and risk, BIOX or BLGO?

Does the media favor BIOX or BLGO?

Do insiders & institutionals hold more shares of BIOX or BLGO?

Is BIOX or BLGO more profitable?

Which has better valuation and earnings, BIOX or BLGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLGO vs. The Competition

BioLargo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools